Concepts (197)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 20 | 2023 | 286 | 6.490 |
Why?
|
| Caregivers | 14 | 2022 | 182 | 5.990 |
Why?
|
| Survivors | 9 | 2022 | 136 | 3.020 |
Why?
|
| Bipolar Disorder | 4 | 2021 | 43 | 1.570 |
Why?
|
| Spouses | 4 | 2016 | 30 | 1.560 |
Why?
|
| Adaptation, Psychological | 5 | 2021 | 385 | 1.340 |
Why?
|
| Interpersonal Relations | 4 | 2020 | 205 | 1.340 |
Why?
|
| Lithium | 2 | 2018 | 15 | 1.180 |
Why?
|
| Health Services Accessibility | 3 | 2023 | 560 | 1.130 |
Why?
|
| Circadian Rhythm | 3 | 2018 | 225 | 1.100 |
Why?
|
| Depression | 6 | 2018 | 712 | 1.090 |
Why?
|
| Alzheimer Disease | 3 | 2022 | 905 | 1.040 |
Why?
|
| Life Expectancy | 2 | 2015 | 42 | 0.940 |
Why?
|
| Middle Aged | 21 | 2021 | 10129 | 0.880 |
Why?
|
| Mortality | 2 | 2015 | 145 | 0.860 |
Why?
|
| Family Relations | 2 | 2020 | 46 | 0.860 |
Why?
|
| Humans | 40 | 2023 | 37093 | 0.840 |
Why?
|
| Depressive Disorder | 2 | 2015 | 174 | 0.810 |
Why?
|
| Health Status | 2 | 2016 | 380 | 0.790 |
Why?
|
| Aged | 15 | 2021 | 6741 | 0.740 |
Why?
|
| Stress, Psychological | 2 | 2016 | 583 | 0.710 |
Why?
|
| Depressive Disorder, Major | 1 | 2021 | 103 | 0.700 |
Why?
|
| Male | 26 | 2021 | 20025 | 0.690 |
Why?
|
| Communication | 2 | 2020 | 180 | 0.690 |
Why?
|
| Psychotherapy | 1 | 2019 | 47 | 0.690 |
Why?
|
| Adult | 17 | 2021 | 11712 | 0.680 |
Why?
|
| United States | 12 | 2020 | 4223 | 0.680 |
Why?
|
| Treatment Outcome | 4 | 2021 | 1369 | 0.680 |
Why?
|
| Female | 25 | 2021 | 20969 | 0.660 |
Why?
|
| Socioeconomic Factors | 6 | 2021 | 1067 | 0.650 |
Why?
|
| Phytic Acid | 1 | 2018 | 4 | 0.630 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2018 | 32 | 0.620 |
Why?
|
| Sex Education | 1 | 2017 | 30 | 0.600 |
Why?
|
| Interviews as Topic | 4 | 2020 | 381 | 0.570 |
Why?
|
| Unemployment | 1 | 2016 | 23 | 0.570 |
Why?
|
| Antimanic Agents | 1 | 2016 | 4 | 0.560 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 2016 | 28 | 0.560 |
Why?
|
| Sick Leave | 1 | 2016 | 2 | 0.550 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2016 | 12 | 0.550 |
Why?
|
| Social Work | 2 | 2020 | 49 | 0.550 |
Why?
|
| Mental Disorders | 2 | 2018 | 309 | 0.550 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2016 | 103 | 0.540 |
Why?
|
| Developmental Disabilities | 1 | 2016 | 61 | 0.530 |
Why?
|
| Chronic Disease | 5 | 2021 | 484 | 0.530 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2016 | 99 | 0.530 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2018 | 404 | 0.520 |
Why?
|
| Primary Prevention | 1 | 2015 | 59 | 0.520 |
Why?
|
| Cause of Death | 2 | 2013 | 156 | 0.520 |
Why?
|
| Employment | 1 | 2016 | 76 | 0.520 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 88 | 0.520 |
Why?
|
| Qualitative Research | 5 | 2020 | 446 | 0.510 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2021 | 389 | 0.510 |
Why?
|
| Aged, 80 and over | 8 | 2021 | 2379 | 0.510 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 77 | 0.510 |
Why?
|
| Patient Selection | 3 | 2023 | 164 | 0.500 |
Why?
|
| Attitude to Health | 1 | 2016 | 325 | 0.460 |
Why?
|
| Poverty | 1 | 2016 | 348 | 0.450 |
Why?
|
| Heart Diseases | 2 | 2013 | 104 | 0.440 |
Why?
|
| Uncertainty | 1 | 2012 | 26 | 0.430 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 358 | 0.420 |
Why?
|
| Students | 1 | 2017 | 519 | 0.410 |
Why?
|
| Aviation | 1 | 2011 | 1 | 0.390 |
Why?
|
| Travel | 1 | 2011 | 32 | 0.380 |
Why?
|
| Mental Health | 1 | 2014 | 303 | 0.370 |
Why?
|
| Smoking | 3 | 2015 | 940 | 0.370 |
Why?
|
| Family | 2 | 2022 | 173 | 0.360 |
Why?
|
| Disabled Persons | 1 | 2011 | 65 | 0.360 |
Why?
|
| Rural Population | 2 | 2023 | 294 | 0.360 |
Why?
|
| Quality of Life | 4 | 2021 | 481 | 0.340 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 664 | 0.340 |
Why?
|
| Substance-Related Disorders | 1 | 2016 | 730 | 0.330 |
Why?
|
| Health Status Disparities | 1 | 2015 | 642 | 0.330 |
Why?
|
| NIH 3T3 Cells | 2 | 2018 | 61 | 0.290 |
Why?
|
| Cross-Sectional Studies | 4 | 2022 | 2721 | 0.290 |
Why?
|
| Risk Factors | 4 | 2016 | 3562 | 0.270 |
Why?
|
| Obesity | 1 | 2013 | 1067 | 0.250 |
Why?
|
| Young Adult | 5 | 2021 | 4268 | 0.250 |
Why?
|
| Cognition Disorders | 2 | 2018 | 233 | 0.240 |
Why?
|
| Phosphorylation | 2 | 2018 | 928 | 0.230 |
Why?
|
| Cognition | 2 | 2020 | 398 | 0.230 |
Why?
|
| Pilot Projects | 3 | 2015 | 661 | 0.210 |
Why?
|
| Veterans | 2 | 2021 | 122 | 0.210 |
Why?
|
| Patient Participation | 1 | 2023 | 75 | 0.210 |
Why?
|
| Age Factors | 3 | 2015 | 1033 | 0.210 |
Why?
|
| Single-Blind Method | 1 | 2021 | 55 | 0.200 |
Why?
|
| Pharmacogenetics | 1 | 2021 | 49 | 0.190 |
Why?
|
| Antidepressive Agents | 1 | 2021 | 50 | 0.190 |
Why?
|
| Aphasia | 1 | 2020 | 2 | 0.190 |
Why?
|
| Videotape Recording | 1 | 2020 | 23 | 0.190 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2012 | 253 | 0.190 |
Why?
|
| Photography | 1 | 2020 | 46 | 0.180 |
Why?
|
| Ankyrins | 1 | 2020 | 6 | 0.180 |
Why?
|
| Health Behavior | 2 | 2016 | 537 | 0.180 |
Why?
|
| Empathy | 1 | 2020 | 28 | 0.180 |
Why?
|
| Prevalence | 2 | 2015 | 1455 | 0.180 |
Why?
|
| Sex Factors | 2 | 2013 | 898 | 0.170 |
Why?
|
| Prospective Studies | 2 | 2021 | 1378 | 0.170 |
Why?
|
| Research Design | 1 | 2020 | 313 | 0.160 |
Why?
|
| Home Care Services | 1 | 2018 | 33 | 0.160 |
Why?
|
| Cooperative Behavior | 1 | 2020 | 219 | 0.160 |
Why?
|
| Emigration and Immigration | 1 | 2018 | 82 | 0.150 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2018 | 31 | 0.150 |
Why?
|
| Spinal Cord Injuries | 1 | 2018 | 56 | 0.150 |
Why?
|
| Emergency Medical Services | 1 | 2018 | 58 | 0.150 |
Why?
|
| Midwestern United States | 1 | 2017 | 19 | 0.150 |
Why?
|
| Perception | 2 | 2021 | 195 | 0.150 |
Why?
|
| Organizational Culture | 1 | 2017 | 14 | 0.150 |
Why?
|
| Genome-Wide Association Study | 2 | 2016 | 333 | 0.150 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 173 | 0.150 |
Why?
|
| ARNTL Transcription Factors | 1 | 2016 | 16 | 0.140 |
Why?
|
| Cohort Studies | 1 | 2021 | 1492 | 0.140 |
Why?
|
| Community-Based Participatory Research | 1 | 2020 | 317 | 0.140 |
Why?
|
| Siblings | 1 | 2016 | 18 | 0.140 |
Why?
|
| Dual Specificity Phosphatase 6 | 1 | 2016 | 1 | 0.140 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2016 | 10 | 0.140 |
Why?
|
| Chromosomes, Human, X | 1 | 2016 | 22 | 0.140 |
Why?
|
| Paresis | 1 | 2016 | 8 | 0.140 |
Why?
|
| Lithium Compounds | 1 | 2016 | 3 | 0.140 |
Why?
|
| Period Circadian Proteins | 1 | 2016 | 37 | 0.140 |
Why?
|
| Fatigue | 1 | 2016 | 83 | 0.140 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2016 | 54 | 0.140 |
Why?
|
| Mice | 2 | 2018 | 5913 | 0.140 |
Why?
|
| Genes, Reporter | 1 | 2016 | 136 | 0.130 |
Why?
|
| Health Care Surveys | 1 | 2016 | 136 | 0.130 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 974 | 0.130 |
Why?
|
| Exercise Therapy | 1 | 2016 | 69 | 0.130 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2016 | 122 | 0.130 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 409 | 0.130 |
Why?
|
| Students, Health Occupations | 1 | 2015 | 6 | 0.130 |
Why?
|
| Dyslipidemias | 1 | 2015 | 43 | 0.130 |
Why?
|
| Cells, Cultured | 2 | 2016 | 1518 | 0.130 |
Why?
|
| Heart Arrest | 1 | 2015 | 35 | 0.130 |
Why?
|
| RNA Interference | 1 | 2016 | 243 | 0.130 |
Why?
|
| Receptor, erbB-2 | 1 | 2016 | 133 | 0.130 |
Why?
|
| Patient Care Team | 1 | 2015 | 47 | 0.130 |
Why?
|
| Hospitalization | 1 | 2018 | 388 | 0.130 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2016 | 173 | 0.130 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 191 | 0.120 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 169 | 0.120 |
Why?
|
| Parents | 1 | 2017 | 329 | 0.120 |
Why?
|
| Patient Compliance | 1 | 2015 | 212 | 0.120 |
Why?
|
| Universities | 1 | 2017 | 442 | 0.120 |
Why?
|
| Activities of Daily Living | 1 | 2014 | 105 | 0.110 |
Why?
|
| DNA Methylation | 1 | 2016 | 325 | 0.110 |
Why?
|
| Developed Countries | 1 | 2013 | 12 | 0.110 |
Why?
|
| Adolescent | 2 | 2016 | 5363 | 0.110 |
Why?
|
| Risk Assessment | 1 | 2015 | 753 | 0.110 |
Why?
|
| Least-Squares Analysis | 1 | 2012 | 43 | 0.110 |
Why?
|
| Health Personnel | 1 | 2015 | 228 | 0.110 |
Why?
|
| Longitudinal Studies | 2 | 2013 | 885 | 0.110 |
Why?
|
| Interview, Psychological | 1 | 2012 | 61 | 0.110 |
Why?
|
| Health Status Indicators | 1 | 2013 | 75 | 0.110 |
Why?
|
| Incidence | 1 | 2015 | 922 | 0.110 |
Why?
|
| Animals | 3 | 2020 | 15081 | 0.100 |
Why?
|
| Length of Stay | 1 | 2013 | 185 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 767 | 0.100 |
Why?
|
| Professional Role | 1 | 2011 | 40 | 0.100 |
Why?
|
| Databases, Factual | 1 | 2011 | 291 | 0.090 |
Why?
|
| Healthcare Disparities | 1 | 2015 | 494 | 0.090 |
Why?
|
| Smoking Cessation | 1 | 2016 | 517 | 0.090 |
Why?
|
| Focus Groups | 1 | 2011 | 348 | 0.080 |
Why?
|
| Emotions | 1 | 2011 | 220 | 0.080 |
Why?
|
| Hypertension | 1 | 2015 | 796 | 0.080 |
Why?
|
| Biomedical Research | 1 | 2011 | 400 | 0.070 |
Why?
|
| Aftercare | 1 | 2021 | 19 | 0.050 |
Why?
|
| Patient Discharge | 1 | 2021 | 93 | 0.050 |
Why?
|
| Japan | 1 | 2021 | 305 | 0.050 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2020 | 57 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2020 | 130 | 0.040 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2018 | 33 | 0.040 |
Why?
|
| Binding Sites | 1 | 2020 | 651 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2020 | 1180 | 0.040 |
Why?
|
| Frontal Lobe | 1 | 2016 | 48 | 0.040 |
Why?
|
| Protein Binding | 1 | 2020 | 972 | 0.040 |
Why?
|
| Exercise Tolerance | 1 | 2016 | 15 | 0.030 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor Receptors | 1 | 2016 | 4 | 0.030 |
Why?
|
| Comorbidity | 1 | 2018 | 623 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2016 | 103 | 0.030 |
Why?
|
| Walking | 1 | 2016 | 68 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2016 | 208 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2016 | 272 | 0.030 |
Why?
|
| Heart Rate | 1 | 2016 | 253 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 578 | 0.030 |
Why?
|
| Gene Expression | 1 | 2016 | 674 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2016 | 1130 | 0.030 |
Why?
|
| Genotype | 1 | 2016 | 730 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2016 | 387 | 0.030 |
Why?
|
| Phenotype | 1 | 2016 | 689 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2018 | 2026 | 0.030 |
Why?
|
| Rats | 1 | 2020 | 3483 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 225 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2011 | 61 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2011 | 519 | 0.020 |
Why?
|
| Time Factors | 1 | 2011 | 1742 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2011 | 485 | 0.020 |
Why?
|
| Exercise | 1 | 2011 | 613 | 0.020 |
Why?
|
| Neoplasms | 1 | 2011 | 1103 | 0.010 |
Why?
|